Protocol for a systematic review of the associations between inflammatory markers and lung function, muscle force and exercise capacity in people with COPD.

Chronic airways disease Rehabilitation medicine Respiratory medicine (see Thoracic Medicine)

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 07 2023
Historique:
medline: 21 7 2023
pubmed: 19 7 2023
entrez: 18 7 2023
Statut: epublish

Résumé

The prevalence of chronic obstructive pulmonary disease (COPD) has been on the rise, with acute exacerbation of COPD associated with the highest burden and multiple pulmonary and systemic consequences. People with COPD have been found to have an abnormal response of systemic inflammation. To date, although limited, there are studies that suggest negative associations between inflammatory markers and important clinical outcomes such as exercise capacity and muscle force. This protocol aims to systematically review the evidence for (i) the associations between inflammatory markers and lung function, muscle force and exercise capacity and (ii) the influence of other factors (eg, hospitalisation, exercise programme) on the level of inflammatory markers in people with COPD. Scopus, PubMed, Cochrane, Web of Science and ProQuest will be searched from database inception to February 2023 using PEO search strategy (Population: adults with COPD; Exposure: inflammatory markers; Outcomes: lung function, muscle force and exercise capacity). Four reviewers working in pairs will independently screen articles for eligibility and extract data that fulfilled the inclusion criteria. Depending on the design of the included studies, either Cochrane risk-of-bias version 2 or the Newcastle-Ottawa Scale tools will be used to rate the methodological quality of the included studies. Effect sizes reported in each individual study will be standardised to Cohen's d and a random effects model will be used to calculate the pooled effect size for the association. Ethical approval is unnecessary as this study will only use publicly available data. The findings will be disseminated through publication in peer-reviewed journals and conferences. CRD42022284446.

Identifiants

pubmed: 37463801
pii: bmjopen-2022-068776
doi: 10.1136/bmjopen-2022-068776
pmc: PMC10357637
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e068776

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Respir Res. 2012 Aug 20;13:71
pubmed: 22906131
Chest. 2006 Mar;129(3):536-44
pubmed: 16537849
Chest. 2007 Mar;131(3):696-704
pubmed: 17356082
COPD. 2008 Aug;5(4):235-56
pubmed: 18671149
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Am J Respir Crit Care Med. 1998 Dec;158(6):1709-14
pubmed: 9847257
Health Econ Rev. 2021 Aug 17;11(1):31
pubmed: 34403023
BMC Med Res Methodol. 2008 Feb 25;8:8
pubmed: 18298827
Thorax. 2002 Oct;57(10):847-52
pubmed: 12324669
Thorax. 2010 Oct;65(10):930-6
pubmed: 20627907
Eur Respir J. 2003 Feb;21(2):347-60
pubmed: 12608452
Eur Respir J. 2019 Jul 18;54(1):
pubmed: 31000678
Chest. 2007 Jul;132(1):127-34
pubmed: 17475631
Respir Res. 2006 May 02;7:70
pubmed: 16669999
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Eur Respir J. 2014 Apr;43(4):1018-27
pubmed: 24389867
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Lancet. 1987 Nov 7;2(8567):1043-6
pubmed: 2889963
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1055-60
pubmed: 8887607
Thorax. 2006 Jan;61(1):10-6
pubmed: 16284220
Thorax. 2003 Sep;58(9):752-6
pubmed: 12947130
J Cardiopulm Rehabil Prev. 2009 Sep-Oct;29(5):318-24
pubmed: 19561523
COPD. 2008 Apr;5(2):133-8
pubmed: 18415812
Int J Chron Obstruct Pulmon Dis. 2012;7:95-9
pubmed: 22371650
Eur Respir J. 2016 Aug;48(2):340-9
pubmed: 27126688
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Nadhirah Mohd Noor (NM)

Centre for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam, Malaysia.

Zawani Mustaffa (Z)

Centre for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam, Malaysia.
Rehabilitation Department, KPJ Bandar Dato' Onn Specialist Hospital, Bandar Dato' Onn, Malaysia.

Alia Nizam (A)

Centre for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam, Malaysia.
Department of Physiotherapy, Sunway Medical Centre, Bandar Sunway, Malaysia.

Mohd Arif Mohd Zim (MA)

Respiratory Medicine, Internal Medicine, KPJ Damansara Specialist Hospital 2, Kuala Lumpur, Malaysia.

Li Whye Cindy Ng (LWC)

Department of Physiotherapy, Singapore General Hospital, Singapore.
Health and Social Sciences Cluster, Singapore Institute of Technology, Singapore.

Fatim Tahirah Mirza (FT)

Centre for Physiotherapy Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam, Malaysia fatim_mirza@uitm.edu.my.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH